| SUNRYTHM | : | First anti-arrythmic drug originated in Japan |
| HANP | : | World’s first commercialized natriuretic peptide |
| BIOPTEN | : | First approved drug containing 6R-BH4(R-tetrahydrobiopterin) |
| Product Name | Generic Name | Indication | Date Launched | Marketing Partner |
|---|---|---|---|---|
| SUNRYTHM (Capsule) 25mg/50mg SUNRYTHM (Injection) 50 |
pilsicainide hydrochloride |
Arrhythmia | 1991 (Capsule) 2000 (Injection) |
Daiichi Sankyo |
| HANP (Injection)1000 | carperitide (atrial natriuretic peptide) |
Acute heart failure | 1995 | Daiichi Sankyo |
| ADENOSCAN (Injection) 60mg | adenosine | Diagnosis of Coronary Artery Disease | 2005 | Daiichi Sankyo |
| BIOPTEN 2.5% (Granule 2.5%) | sapropterin hydrochloride (tetrahydrobiopterin) | Inherited metabolic disease | 1992 | Daiichi Sankyo |
Note: The above products are available by prescription only.